Megan Cavallo

Megan Cavallo

Manager, Business Operations and Human Resources

Megan Cavallo is a Boston-based healthcare manager with experience in Pharmacovigilance and Clinical Research. Megan joined the Fiore Healthcare Advisors team in 2015 as associate consultant and is currently the Manager of Business Operations & Human Resources.

In this role, Megan is responsible for the management of multiple cross-functional initiatives to drive long term business sustainability. She oversees day to day operations and is charged with improving processes to minimize complexity and foster effective operations. In 2017, Megan completed her ‘Clinical Project Management’ Certificate Program through Barnett International. As a Project Manager, Megan provides support to a wide variety of clients to ensure collaborative engagement, targeted business strategies and risk analyses from project inception to execution.

During her time with FHA, Megan has coordinated and managed activities related to Safety Oversight and Support, interim Pharmacovigilance (PV) Leadership Support, PV Operating Models and Medical Monitoring Programs. Megan has also organized activity execution to support the on-time delivery of a high-quality Investigational New Drug (IND) Application. Moreover, Megan has experience managing medical oversight committees, including a Dose Escalation Committee, a Data Safety Monitoring Board and a Safety Assessment Committee. In addition to client-facing functions, Megan plans, directs and coordinates an array of administrative functions, including managing multi-state tax accounts, supervising new employee onboarding and handling billing.

Originally from Massachusetts, Megan graduated with a B.S. in Biology from the University of Massachusetts, Amherst. As an undergraduate, Megan joined a team of scientists and medical professionals to conduct a field study in the Amazon Rainforest where she worked with the local shamans of Peru to study the employment of natural substances within aboriginal cultures, herbal medicines and modern pharmaceuticals.